newsfilter
← Latest News
PR Newswire·

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers & directors of Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) regarding alleged self-dealing.
  • The investigation may lead to shareholder damages & corporate governance reforms.
  • Long-term RYTM stockholders can contact Justin Kuehn, Esq. via email at [email protected] or by calling (833) 672-0814 for a free consultation.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • Shareholders are urged to contact the firm immediately due to potential time limits on enforcing their rights.
  • The firm states that attorney advertising prior results do not guarantee similar outcomes.